Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.

Source:http://linkedlifedata.com/resource/pubmed/id/17581163

Download in:

View as

General Info

PMID
17581163